Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting microRNAs for metabolic disorders

Targeting microRNAs for metabolic disorders

US Patent 9862950 · Granted Jan 9, 2018

Estimated economic value: $2,645,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acid conjugates and uses thereof2025
MicroRNA compounds and methods for modulating mir-21 activity2025
Nanoparticle formulations for delivery of nucleic acid complexes2025
Compositions and methods for facilitating delivery of synthetic nucleic acids to2024
Nucleic acid conjugates and uses thereof2022
Increasing RNAi efficiency through single nucleotide mismatches2021
Compositions comprising alternating 2′-modified nucleosides for use in gene modu2021
Compounds and methods for enhanced cellular uptake2021
RNA sequence-specific mediators of RNA interference2019
Compositions comprising alternating 2′-modified nucleosides for use in gene modu2019
Compounds and methods for enhanced cellular uptake2019
MicroRNA compounds and methods for modulating miR-1222018